• September 27, 2020
    • Loading stock data...
  • Federal Commission Pushes Expansion Of Marijuana And Psychedelics Research For Military Veterans

    LinkedIn

    A federal commission tasked with developing recommendations to improve mental health treatment for military veterans has reached a surprising conclusion: Congress and the executive branch need to promote research into the therapeutic potential of marijuana and psychedelics such as psilocybin mushrooms and MDMA.

    Following months of meetings, the Creating Options for Veterans Expedited Recovery (COVER) Commission released its report in January. But despite the novelty of its drug policy findings, the document has gone largely unnoticed by reform advocates and the media. Chaired by presidential appointee Jake Leinenkugel, the panel determined that cannabis and psychedelics represent promising mental health treatment options for veterans that should be fully explored.

    “Medical cannabis and psychedelic drugs may have uses in treating mental health issues among veterans; however, these substances are currently classified as Schedule 1 under the Controlled Substances Act, which precludes VA from conducting research on their efficacy,” the panel said.

    Read full article here: https://www.marijuanamoment.net/federal-commission-pushes-expansion-of-marijuana-and-psychedelics-research-for-military-veterans/

    Share.

    About Author

    Comments are closed.